We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Lupin has launched Penicillamine tablets, used to treat Wilson’s disease, in the US market.The company has launched a generic product in the market after having received approval from the US and Drug Administration (US FDA) earlier.